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INTRODUCTION
Superior soft tissue contrast is a major advantage of magnetic resonance imaging (MRI) over alternative medical imaging modalities such as computed tomography (CT) and Xray [1] , [2] . The difference of spin-lattice (T 1 ) and spin-spin (T 2 ) relaxation times among tissues, is the origin of the unique soft tissue contrast in MRI. However, in some applications, difference in relaxation parameters may be insufficient to provide reliable discrimination of tissue structure. In these instances, the use of contrast agents that alter relaxivity can significantly enhance the contrast between target tissues and the background. These contrast agents are usually in the form of T 1 or T 2 contrast agents [3] , [4] , [5] , [5] , [6] . T 1 agents are commonly paramagnetic materials that increase longitudinal relaxivity and thereby yield higher signal levels [7] , [8] . While superparamagnetic iron oxide nanoparticles (SPIONs) with ultrasmall size (e.g., around 3 nm diameter) can also be used as T 1 contrast agents, currently the Gadolinium species with seven unpaired electrons are the dominant positive contrast agent used in clinical applications [9] , [10] . On the other hand, T 2 agents are typically SPIONs that induce magnetic field perturbations and increase transverse relaxivity, which in turn reduces signal levels [11] , [12] , [13] . However, the difficulty in distinguishing a region of weak signal due to SPIONs from regions that suffer from other sources of signal loss (e.g., susceptibility differences among tissues, B 0 field inhomogeneity) is a drawback of T 2 contrast agents [14] , [15] , [16] . One solution to this problem is to utilize SPIONs as dual-modal contrast agents. In MRI, T 1 -weighted images typically provide better spatial resolution, while T 2 -weighted images can provide enhanced detection of lesions [17] .
Hence, a synergistic combination of T 1 -and T 2 -contrast-enhanced imaging can potentially provide more comprehensive imaging information and lead to higher diagnostic accuracy [18] .
To date, numerous studies have considered developing methods for synthesizing simultaneous T 1 and T 2 contrast agents. For this purpose, hybrid nanoparticles have recently been developed, where the Gadolinium species integrated with iron oxide nanoparticles in a core-shell format systematically demonstrated the feasibility of such
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A C C E P T E D M A N U S C R I P T 4 hybrid probes [19] . In another study, Mn−Fe heterodoped ZnSe tetrapod nanocrystals were proposed to simultaneously enhance contrast in both T 1 -and T 2 -weighted MRI [20] . However, the use of hybrid materials as in these two examples may cause magnetic interactions of nanoparticles, which in turn result in the perturbation of the relaxation process [21] . An alternative method for achieving dual-mode contrast agent is to utilize a single material for enabling multiple contrasts. For example, Jung et al. generated both negative and positive image contrasts by manipulating the pulse sequences together with the use of size-controlled SPIONs [22] . In another study, T 1 -weighted positive contrast obtained from SPIONs using ultrashort-echo-time was reported by Kwon et al. [23] . In the clinic, Ferumoxytol (an ultrasmall SPION) can be utilized to obtain regional T 1 and T 2 * signal enhancement or loss with conventional pulse sequences [24] . However, SPION's performance as MRI contrast agents strongly depends on their size and shape. Hence, as dual-mode contrast agents are gaining interest, there is a strong need to investigate both features to reach a high performance synergistic contrast agent.
In this study, by taking advantage of the strong shape and size dependence of SPION's performance, we synthesized a new class of cubic SPIONs as a synergistic T 1 -and T 2 -contrast-enhancement agent for MRI. We compared the performance of these cubic SPIONs with their spherical counterparts via measurements of molar relaxivities (r 1 and r 2 ) on a 3T MRI scanner. Here, we used silica for surface modification, since previous reports showed negligible toxicity level for nano-sized silica shells. As a feasibility study, both positive and negative contrast effects of 11-nm cubic SPIONs were demonstrated in-vivo on T 1 -and T 2 -weighted spin-echo MRI images obtained before and after intravenous injection of 1 mg/kg contrast agent trough the tail vein of a Sprague-Dawley rat.
MATERIALS and METHODS

Theory
The magnetic properties of SPIONs are affected by their crystallinity and size, which in turn significantly affects the MR relaxivity properties of the SPIONs. Accordingly, as the
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A C C E P T E D M A N U S C R I P T 5 particle size increases the corresponding saturation magnetization increases, enhancing the T 2 (transverse) relaxation of the surrounding tissue. On the other hand, as the particle size decreases, both the surface-to-volume ratio and the percentage of unpaired electrons on the particle surface increases. The interaction of unpaired electrons with the protons of water molecules reduces the T 1 (longitudinal) relaxation time of the protons and results in MRI signal enhancement, and this effect is more pronounced for small-sized SPIONs [25] . In addition, the reduced magnetic moments of these smaller particles suppress their T 2 effect. Moreover, particles with sharp surfaces (for example cubic particles) possess higher surface-to-volume ratio in comparison with spherical particles, causing them to exhibit improved T 1 and T 2 effects. Therefore, the shape anisotropy and large effective region of magnetic cores in cubic samples can increase their T 2 -contrast-enhancement capabilities, and large surface-to-volume ratio and consequently a large number of unpaired electrons on their cubic surface can increase their T 1 -contrast-enhancement capabilities [26] , [27] .
In the well-known form, T 1 and T 2 can be represented in terms of their corresponding R 1
and R 2 relaxation rates, respectively [28] . The relaxation rates are functions of , and iron concentration (C) in mM. Using the standard linear relaxivity approximation, the relaxation rate can be written as:
where In the current study, the MR contrast optimization is conducted with multi-echo spinecho sequences and inversion recovery sequences for transverse and longitudinal relaxation estimation, respectively. Under these approximations, the T 1 -weighted and T 2 -weighted signals can be estimated by the following equations:
For longitudinal relaxation:
and for transverse relaxation:
Here, TE is the echo time, TI is the inversion time, TR is the repetition time, and is the thermal equilibrium value of bulk magnetization vector. TE and TI are image acquisition parameters controlled by the operator. T 1 and T 2 depend on the surrounding medium and the magnetic field strength.
As the contrast agents shorten the spin-lattice and spin-spin relaxation times, the ratio of their molar relaxivities (α = r 2 /r 1 ) is generally used to describe the dominant contrast agent features and their contrast enhancement efficiency [29] . Accordingly, α is a parameter comparing the effectiveness of T 1 and T 2 contrast mechanisms, and this parameter strongly depends on particle properties, contrast regime, and B 0 field strength [30] .
Materials
For the synthesis of SPIONs, the following materials were obtained from Sigma-Aldrich argon flow. The growth of the SPIONs was done at 320 °C for 30 min. Following the growth, the solution was cooled down to room temperature and SPIONs were cleaned with 2-propanol and acetone for three times. Then, SPIONs were dispersed in 16 mL of hexane and filtered using 0.2 µm Millipore filter. In this work, we achieved the differences in the size and shape of SPIONs by varying the oleic acid amount, heating rate, and iron-oleate amount of the mixture.
Surface Modification
Principally, nanoparticles must possess low toxicity and good colloidal stability in a biological environment to be suitable for in-vivo applications, which mandates a surface modification of these nanoparticles. Formation of biocompatible shells surrounding the nanoparticles is a typical method for surface modification. Briefly, 10 mL of cyclohexane and 1.3 mL of Igepal-CO520 (polyoxyethylene (5) nonyl phenyl ether) were stirred for 15 min to obtain a microemulsion dispersion. Followed by the addition of 1.5 mg iron oxide nanoparticles (in 1.6 mL of cyclohexane), the mixture was continuously stirred for further 15 min. Subsequently, 40 µL of TEOS was added, and the solution was stirred for 30 min in the dark. Finally, 150 µL of ammonium hydroxide (1.5%) solution was added, and the mixture was stirred for 72-hour. For the cleaning of resulting silicacoated iron oxide nanoparticles, the solution was centrifuged at 10000 rpm for 20 min.
After discarding the supernatant, 10 mL of ethanol was added, and the nanoparticles were dispersed using an ultrasonic bath. This dispersion was centrifuged at 10000 rpm for 40 min, and the same procedure was repeated one more time. At the end, the ACCEPTED MANUSCRIPT
supernatant was removed, and 6 mL of autoclaved ddH 2 O and 24 µL of 2 M sodium hydroxide (NaOH) solution was added.
Characterization
Morphological structures of the iron oxide nanoparticles were investigated using an FEI Tecnai G2 F30 transmission electron microscopy (TEM). Before imaging, 2 µL of iron oxide nanoparticle solution in hexane was dropped on a 200 mesh copper grid, and the sample was dried. Dynamic light scattering (DLS) measurement was conducted to study nanoparticles size distributions. After several repetitions, 10 µL of the mixed solution was picked up to count the number of living cells using automated cell counter.
In-vitro
In-vivo MR Imaging
In-vivo MRI experiments were approved by the institutional Animal Ethics Committee and performed by the national standards of animal care. Sprague Dawley rat (250-300 gr) was obtained from institutional Animal Laboratory and were maintained in standard laboratory conditions. In-vivo MRI studies were conducted with 3T MRI scanner. The rat was placed headfirst inside an in-house-developed cylindrical 5-cm-diameter birdcage rat MRI coil. This custom receive coil was used for all of our in-vivo experiments.
Due to their small-size advantage and high T 1 -and T 2 -contrast-enhancement (see To observe the synergistic contrast effect, healthy anesthetized rat was imaged before, and 5-min, 35-min, 70-min, 90-min, and 18-hour after intravenous injection of 1 mg/kg 11-nm cubic silica-coated SPIONs. A conventional spin-echo sequence (TR/TE = 1000 ms / 11 ms, 2 mm slice thickness, and 320×320 matrix size) was performed to obtain T 1 -weighted anatomical scans. T 2 -weighted spin-echo imaging was conducted with the following parameters: TR/TE = 4000 ms / 90 ms, 2 mm slice thickness, and 320×320 matrix size.
Contrast Enhancement Analysis
The in-vitro and in-vivo SPION-induced contrast enhancement analysis was performed using calculation of contrast-to-noise ratio (CNR), SNR, and percentage of contrast enhancement (C Enh ).
For in-vitro contrast enhancement analysis, 0.4 mM of all six types of SPIONs as well as a reference sample (without contrast material) were prepared on 2 mL vials. We used inversion recovery (TR=3000 ms, TE=12 ms and TI=600 ms) and multi-echo spin-echo (TR=2000 ms, TE=100 ms) MRI sequences to analyze the T 1 -and T 2 -contrastenhancement, respectively. In-vivo contrast enhancement analysis was performed on the images resulting from the experiments described in the in-vivo MR Imaging section above.
For each image group, SNR analysis was performed to determine the signal variations on the ROI with and without contrast agents. The signal intensities were gathered for all
given pixels within a ROI, then mean signal intensity was calculated. The SNR was calculated by dividing mean signal intensity of ROI by standard deviation of noise.
The C Enh in the phantom and in-vivo were calculated using the following equation:
where I post and I pre are the mean signal intensities of the ROI with and without SPIONs, respectively.
The CNR was calculated using the following equations:
where I ROI and I REF are the mean signal intensities of the ROI and a reference region, respectively. σ N is the standard deviation of noise. For in-vivo contrast enhancement analysis, we focused on the kidneys as the ROI, and psoas minor muscle was selected as the reference region to calculate SNR, CNR, and C Enh (Fig 5, 6 ).
RESULTS
Synthesis of Silica-Coated SPION and Characterization
Spherical and cubic SPIONs with the size of 7 nm, 11 nm, and 14 nm were synthesized using the thermal decomposition method. TEM was utilized for the morphological and structural characterizations of iron oxide nanocrystals. Representative TEM images and a comparison of core sizes of the synthesized SPIONs reveal that the particles are monodisperse, well separated in a solvent, and do not aggregate. An example TEM image corresponding to the 11-nm cubic SPIONs is shown in Figure 1a . DLS measurements of the same SPIONs is given Figure 1b, showing a hydrodynamic size of up to ~18 nm.
In-vitro Relaxivity Analysis of Synthesized SPIONs
In-vitro T 1 and T 2 relaxation times of all prepared vial phantoms as a function of the iron concentration were calculated for all samples. The relaxation times were determined by ACCEPTED MANUSCRIPT
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12 nonlinear fitting of the signal intensities (Fig. 2b ). An example T 1 -weighted image shown in Figure 2a shows that mean signal intensities of the phantoms first go down and then increase with increasing iron concentration, due to inversion recovery. In the T 2 -weighted images, by increasing the iron concentration the mean signal intensities decrease. As expected, the relaxation rates (R 1 and R 2 ) increase linearly with increasing iron concentration of the nanoparticles. More importantly, the longitudinal and transverse molar relaxivities, r 1 and r 2 , of both the spherical and cubic SPIONs show a trend of increasing values with increasing particles size (Fig. 3a, b ).
When compared with spherical SPIONs, the cubic SPIONs show a 1. , indicating negligible toxicity.
In-vivo Experiments
In-vivo T 1 -and T 2 -contrast-enhancement analysis performed on the selected ROI at six different time points is summarized in Table 2 
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In-vivo T 1 -and T 2 -weighted spin-echo images in rat kidney pre-and 70-min postinjection of the 11-nm silica-coated cubic SPIONs are shown in Figure 5 and Figure 6 , respectively. The first, second, and third rows of the figures show coronal, sagittal, and transversal images from spin-echo acquisitions before and after injection of the contrast agent, respectively. At 70-min post-injection, the kidney region appears brighter on the T 1 -weighted spin-echo images, demonstrating the positive contrast improvement of the 11-nm cubic SPIONs. The ROI is surrounded by the red dashed circle (Fig. 5) .
Likewise, abdominal T 2 -weighted spin-echo images taken 70 min after injection show that kidney turned to darker, demonstrating the negative contrast-enhancement of the 11-nm cubic SPIONs. The negatively-enhanced region that we focused as ROI is marked by the red dashed circle (Fig. 6 ).
The analysis of the C Enh and SNR in the kidney region at 70-min post-injection indicated that contrast is enhanced in the region of interest on both the T 1 -and T 2 -weighted acquisitions. As given in Table 2 , post-injection C Enh analysis in the kidney region resulted in 64% contrast enhancement on T 1 -weighted transversal images. Also, C Enh study reported 48% contrast enhancement on T 2 -weighted transversal images. These results demonstrate the feasibility of using the 11-nm cubic SPIONs to synergistically enhance the contrast on both T 1 -and T 2 -weighted in-vivo MR imaging.
DISCUSSION
The need for a synergistic positive and negative contrast enhancing and safe MRI contrast agent that can be utilized in clinical diagnosis has attracted the interest of many research groups [18], [19] . The combination of both T 1 -contrast-enhanced image with high spatial resolution and T 2 -contrast-enhanced image with increased lesion detection capability allows complementary anatomic and pathologic information [20] . In this study, by controlling the shape and size of the SPIONs, we targeted a new class of synergistic MRI contrast agents. We synthesized two different groups of nanoparticles, in spherical and cubic shapes. Our investigations resulted in two main findings: First, experimental analysis on both the spherical and cubic iron oxides showed an increase of r 1 and r 2 as the size increases. More importantly, in comparing the two groups of the synthesized
SPIONs, cubic SPIONs showed higher molar relaxivities (r 1 and r 2 ) than their spherical counterparts. This observation can be explained by increased surface-to-volume ratio and spin canting effects in the large surfaces and sharp edges of the cubic samples [26] , [27] . Also, α = r 2 /r 1 ratio was larger for the same-sized cubic nanoparticles when compared to spherical nanoparticles, because of the relatively large increases in r 2 . Invitro contrast enhancement analysis results showed that 11-nm cubic SPIONs can be an optimal sample as a synergistic contrast agent for in-vivo MRI experiments.
Second, as a proof-of-concept feasibility study, we showed that 11-nm cubic SPIONs are promising candidates as a single agent for synergistic contrast in MRI. The results of the in-vivo experiments were in agreement with the in-vitro relaxivity and contrast enhancement analysis of the 11-nm cubic SPIONs. It should be noted that the in-vivo SNR and C Enh was lower than the in-vitro case, which could be due to the reduced invivo iron concentration in the kidney, as well as environmental differences between the in-vitro and in-vivo cases (such as the T 1 and T 2 of the in-vitro medium vs. that of the kidney tissue before injection), and differences in pulse sequence parameters.
Gadolinium complexes are the most commonly used T 1 contrast agents in MRI. In contrast to SPIONs, however, gadolinium complexes have short blood half-life. As reported in the literature, MR images show high contrast immediately after injection of gadolinium, but this effect vanishes rapidly. The SPIONs are shown to maintain the enhancement of contrast at a high value for more than 1 h, while the gadoliniumenhanced contrast drops within 3 min [15] . This rapid reduction restricts the usage of gadolinium complexes in conjunction with long scan time (e.g., longer than 10 min). The contrast enhancement analysis of the proposed cubic SPIONs also showed that the highest contrast level was maintained at a constant level between 70-min and 90-min after injection, providing a wide window for in-vivo imaging. Furthermore, the free gadolinium ions from various labels of gadolinium complexes are known to be very toxic [31] , [32] . SPIONs, on the other hand, are known to have increased biocompatibility and can even be used safely for iron therapy in humans [33] .
By taking advantage of both positive and negative contrast effect using a single contrast material, the proposed contrast agent may be used as a promising synergistic contrast tracer. It should be noted that the MR signal intensity and contrast effects are Example signal-to-time curves of T 1 recovery (left) and T 2 decay (right) of 11-nm cubic SPIONs obtained by inversion recovery and multi-echo spin-echo sequences, respectively. The data points are fitted to mono-exponential functions given in Eqs. [3] and [4] were obtained using inversion recovery sequences: TR= 3000 ms, TE= 12 ms, TI=700
ms. T 2 -weighted images were obtained using multi-echo spin-echo sequences:
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